Ongoing FDA Modernization Is Focus Of AdvaMed 2001 Legislative Spotlight
This article was originally published in The Gray Sheet
Executive Summary
A congressional hearing tentatively scheduled to take place by mid-2001 will examine the ability of FDA to approve breakthrough medical technology in a timely fashion, according to the medical device trade group AdvaMed.
You may also be interested in...
Oversight Chairman Greenwood Familiar With Third-Party Review Program
Any legislative proposal to expand FDA's third-party review program to applications containing clinical data would have a powerful ally in Rep. Jim Greenwood (R-Penn.), the newly named chair of the House Energy and Commerce/Oversight Subcommittee.
Oversight Chairman Greenwood Familiar With Third-Party Review Program
Any legislative proposal to expand FDA's third-party review program to applications containing clinical data would have a powerful ally in Rep. Jim Greenwood (R-Penn.), the newly named chair of the House Energy and Commerce/Oversight Subcommittee.
Device Lobbyist Kimbell Serving On Bush HHS Transition Advisory Team
Jeff Kimbell is the device industry's point-person on the incoming administration's Health and Human Services transition advisory team.